Postmortem diagnosis of unsuspected diabetes mellitus

Forensic Science International

Volumn 226, Issue 1-3, 2013, Pages 160-167

  Palmiere, Cristian ^a   Bardy, Daniel ^b   Mangin, Patrice ^a   Werner, Dominique ^b  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Beta hydroxybutyrate; Diabetes; Glycated hemoglobin; Ketoacidosis; Postmortem biochemistry; Vitreous humor

Indexed keywords

3 HYDROXYBUTYRIC ACID; C REACTIVE PROTEIN; COCAINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 6;

ADOLESCENT; ADULT; ARTICLE; AUTOPSY; BACTERIAL INFECTION; BLOOD SAMPLING; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; FEMALE; GLYCEMIC CONTROL; HISTOLOGY; HUMAN; MALE; MEDICOLEGAL ASPECT; PRIORITY JOURNAL; SEPSIS; TOXICOLOGY; VITREOUS BODY;

EID: 84875598347     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2013.01.004     Document Type: Article

References (114)

1. John W.G., Scott K.W., Hawcroft D.M. Glycated haemoglobin and glycated protein and glucose concentrations in necropsy blood samples. J. Clin. Pathol. 1988, 41:415-418.
2. Luna A. Is postmortem biochemistry really useful? Why is it not widely used in forensic pathology?. Leg. Med. (Tokyo) 2009, (Suppl. 1):s27-s30.
3. Maeda H., Zhu B.L., Ishikawa T., Quan L., Michiue T. Significance of postmortem biochemistry in determining the cause of death. Leg. Med. (Tokyo) 2009, (Suppl. 1):s46-s49.
4. Maeda H., Ishikawa T., Michiue T. Forensic biochemistry for functional investigation of death: concept and practical application. Leg. Med. (Tokyo) 2011, 13:55-67.
5. Palmiere C., Lesta M.D.M., Sabatasso S., Mangin P., Augsburger M., Sporkert F. Usefulness of postmortem biochemistry in forensic pathology: illustrative case reports. Leg. Med. (Tokyo) 2012, 14:27-35.
6. Coe J.I. Postmortem chemistry update. Emphasis on forensic application. Am. J. Forensic Med. Pathol. 1993, 14:91-117.
7. Khuu H.M., Robinson C.A., Brissie R.M., Konrad R.J. Postmortem diagnosis of unsuspected diabetes mellitus established by determination of decedent's hemoglobin A1c level. J. Forensic Sci. 1998, 44:643-646.
8. Karlovsek M.Z. Postmortem diagnosis of diabetes mellitus and diabetic coma: a comparison of HbA1, glucose, lactate and combined glucose and lactate values in vitreous humor and in cerebrospinal fluid. Advances in Forensic Sciences: Forensic Criminalistic 2 1995, vol. 4:38-48. Verlag Dr Köstner, Berlin.
9. Karlovsek M.Z. Diagnostic values of combined glucose and lactate values in cerebrospinal fluid and vitreous humor-our experiences. Forensic Sci. Int. 2004, 146(Suppl.):s19-s23.
10. Zilg B., Alkass K., Berg S., Druid H. Postmortem identification of hyperglycemia. Forensic Sci. Int. 2009, 185:89-95.
11. Boulagnon C., Garnotel R., Fornes P., Gillery P. Postmortem biochemistry of vitreous humor and glucose metabolism: an update. Clin. Chem. Lab. Med. 2011, 49:1265-1270.
12. Palmiere C., Mangin P. Postmortem chemistry update part I. Int. J. Legal. Med. 2012, 126:187-198.
13. Palmiere C., Sporkert F., Vaucher P., Werner D., Bardy D., Rey F., Lardi C., Brunel C., Augsburger M., Mangin P. Is the formula of Traub still up to date in antemortem blood glucose level estimation?. Int. J. Legal. Med. 2012, 126:407-413.
14. Kernbach G., Pitch S., Brinkmann B., Püschel K. Initial results of postmortem diagnosis of diabetes mellitus by Hb A1 determination. Z. Rechtsmed. 1983, 90:303-308.
15. Chen C., Glagov S., Mako M., Rochman H., Rubenstein A.H. Post-mortem glycosylated hemoglobin (HbA1c): evidence for a history of diabetes mellitus. Ann. Clin. Lab. Sci. 1983, 13:407-410.
16. Hindle E.J., Rostron G.M., Gatt J.A. The diagnostic value of glycated haemoglobin levels in post-mortem blood. Ann. Clin. Biochem. 1985, 22(Pt 2):144-147.
17. Valenzuela A. Postmortem diagnosis of diabetes mellitus. Quantitation of fructosamine and glycated hemoglobin. Forensic Sci. Int. 1988, 38:203-208.
18. Maruna P., Skrha J., Strejc P. Serum fructosamine after death. Diab. Med. 1989, 6:460.
19. Hindle E.J. Glycated haemoglobin and glycated protein and glucose concentrations in necropsy blood samples. J. Clin. Pathol. 1989, 42:559.
20. Akane A., Shiono H., Matsubara K., Tanabe K., Nakamura H., Hasegawa M., Kagawa M. Analysis of glycated albumin in postmortem blood samples as the diagnostic parameters of diabetes mellitus. Nihon. Hoigaku Zasshi. 1992, 46:237-243.
21. Goullé J.P., Lacroix C., Bouige D. Glycated hemoglobin: a useful post-mortem reference marker in determining diabetes. Forensic Sci. Int. 2002, 128:44-49.
22. Wineker R.E., Hammett-Stabler C.A., Chapman J.F., Ropero-Miller J.D. HbA1c as a postmortem tool to identify glycemic control. J. Forensic Sci. 2002, 47:1373-1379.
23. Keltanen T., Sajantila A., Valonen T., Vanhala T., Lindroos K. Measuring postmortem glycated hemoglobin-a comparison of three methods. Leg. Med. (Tokyo) 2012, 10.1016/j.legalmed.2012.09.002.
24. Kitabchi A.E., Umpierrez G.E., Miles J.M., Fisher J.N. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009, 32:1335-1343.
25. de Vries L., Oren L., Lebenthal Y., Shalitin S., Lazar L., Philip M. Decrease in frequency of ketoacidosis at diabetes onset over the past two decades-perspectives of a paediatric tertiary care centre. Diabet. Med. 2012, 29:e170-e175.
26. Oyarzabal Irigoyen M., García Cuartero B., Barrio Castellanos R., Torres Lacruz M., Gómez Gila A.L., González Casado I., Hermoso López F., Luzuriaga Tomás C., Rica Etxebarrial I., López García M.J., Rodríguez Rigual M. Ketoacidosis at onset of type 1 diabetes mellitus in pediatric age in Spain and review of the literature. Pediatr. Endocrinol. Rev. 2012, 9:669-671.
27. Klingensmith G.J., Tamborlane W.V., Wood J., Haller M.J., Silverstein J., Cengiz E., Shanmugham S., Kollman C., Wong-Jacobson S., Beck R.W. Pediatric diabetes consortium diabetic, ketoacidosis at diabetes onset: still an all too common threat in youth. J. Pediatr. 2012, http://dx.doi.org/10.1016/j.jpeds.2012.06.058.
28. Usher-Smith J.A., Thompson M.J., Sharp S.J., Walter F.M. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ 2011, 343:d4092. 10.1136/bmj.d4092.
29. Elding Larsson H., Vehik K., Bell R., Dabelea D., Dolan L., Pihoker C., Knip M., Veijola R., Lindblad B., Samuelsson U., Holl R., Haller M.J., TEDDY Study Group, SEARCH Study Group, Swediabkids Study Group, DPV Study Group, Finnish Diabetes Registry Study Group Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care 2011, 34:2347-2352.
30. Habib H.S. Frequency and clinical characteristics of ketoacidosis at onset of childhood type 1 diabetes mellitus in Northwest Saudi Arabia. Saudi Med. J. 2005, 26:1936-1939.
31. Stipancić G., La Grasta Saboli L., Pozgaj Sepec M., Radica A., Skrabi V., Severinski S., Kujundzi Tiljak M. Regional differences in incidence and clinical presentation of type 1 diabetes in children aged under 15 years in Croatia. Croat. Med. J. 2012, 53:141-148.
32. Kanwak S.K., bando A., Kumar V. Clinical profile of diabetic ketoacidosis in Indian children. Indian J. Pediatr. 2012, 79:901-904.
33. Formosa N., Calleja N., Torpiano J. Incidence and modes of presentation of childhood type 1 diabetes mellitus in Malta between 2006 and 2010. Pediatr. Diabetes 2012, 13:484-488.
34. Wolsdorf J., Craig M.E., Daneman D., Dunger D., Edge J., Lee W., Rosenbloom A., Sperling M., Hanas R. Diabetic ketoacidosis in children and adolescent with diabetes. Pediatr. Diabetes 2009, 10(Suppl.):118-133.
35. Lévy-Marchal C., Patterson C.C., Green A., EURODIAB ACE Study Group Europe and diabetes, geographical variation of presentation at diagnosis of type 1 diabetes in children: the EURODIAB study. European and diabetes. Diabetologia 2001, 44(Suppl.):B75-B80.
36. Neu A., Hofer S.E., Karges B., Oeverink R., Rosenbauer J., Holl R.W. DPV Initiative and the German BMBF Competency Network for diabetes mellitus, ketoacidosis at diabetes onset is still frequent in children and adolescents: a multicenter analysis of 14,664 patients from 106 institutions. Diabetes Care 2009, 32:1647-1648.
37. Kulayat N.A., Narchi H. Clinical picture of childhood type 1 diabetes mellitus in the Eastern Province of Saudi Arabia. Pediatr. Diabetes 2001, 2:43-47.
38. Sadauskaite-Kuehne V., Samuelsson U., Jasinskiene E., Padaiga Z., Urbonaite B., Edenvall H., Ludvigsson J., DEBS Study Group Severity at onset of childhood type 1 diabetes in countries with high and low incidence of the condition. Diabetes Res. Clin. Pract. 2002, 55:247-254.
39. Hekkala A., Knip M., Veijola R. Ketoacidosis at diagnosis of type 1 diabetes in children in northern Finland: temporal changes over 20 years. Diabetes Care 2007, 30:861-866.
40. Abdul-Rasoul M., Al-Mahdi M., Al-Qattan H., Al-Tarkait N., Alkhouly M., Al-Safi R., Al-Shawaf F., Mahmoud M. Ketoacidosis at presentation of type 1 diabetes in children in Juwait: frequency and clinical characteristics. Pediatr. Diabetes 2010, 11:351-356.
41. Bui T.P., Werther G.A., Cameron F.J. Trends in diabetic ketoacidosis in childhood and adolescence: a 15-yr experience. Pediatr. Diabetes 2002, 3:82-88.
42. Schober E., Waldhoer T., Rami B., Hofer S., Austrian Diabetes Incidence Study Group Incidence and time trend of type 1 and type 2 diabetes in Austrian children 1999-2007. J. Pediatr. 2009, 155:190-193.
43. Usher-Smith J.A., Thompson M., Ercole A., Walter F.M. Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review. Diabetologia 2012, 55:2878-2894.
44. Imagawa A., Hanafusa T., Miyagawa J., Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Psaka IDDM Study Group. N. Engl. J. Med. 2000, 3:301-307.
45. Hanafusa T., Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3:36-45.
46. Lu J., Zhou J., Bao Y., Chen T., Zhang Y., Zhao A., Qiu Y., Xie G., Wang C., Jia W., Jia W. Serum metabolic signatures of fulminant type 1 diabetes. J. Proteome Res. 2012, 11:4705-4711.
47. Imagawa A., Hanafusa T., Uchigata Y., Kanatsuka A., Kawasaki E., Kobayashi T., Shimada A., Shimizu I., Toyoda I., Maruyama T., Makino H. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care 2003, 26:2345-2352.
48. Cho Y.M., Kim J.T., Ko K.S., Yang B.K., Park M.H., Lee H.K., Park K.S. Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes. Diabetologia 2007, 50:2276-2279.
49. Iten P.X., Meier M. Beta-hydroxybutyric acid-an indicator for an alcoholic ketoacidosis as cause of death in deceased alcohol abusers. J. Forensic Sci. 2000, 45:624-632.
50. Ruell P.A., Gass G.C. Enzymatic measurement of 3-hydroxybutyrate in extracts of blood without neutralization. Ann. Clin. Biomed. 1991, 28:183-184.
51. Tsokos M., Reichelt U., Nierhaus A., Püschel K. Serum procalcitonin (PCT): a valuable biochemical parameter for the postmortem diagnosis of sepsis. Int. J. Legal Med. 2001, 114:237-243.
52. Tsokos M., Reichelt U., Jung R., Nierhaus A., Püschel K. Interleukin-6 and C-reactive protein serum levels in sepsis-related fatalities during the early postmortem period. Forensic Sci. Int. 2001, 119:47-56.
53. Uhlin-Hansen L. C-reactive protein (CRP), a comparison of pre- and postmortem blood levels. Forensic Sci. Int. 2001, 124:32-35.
54. Fujita M.Q., Zhu B.L., Ishida K., Quan L., Oritani S., Maeda H. Serum C-reactive protein levels in postmortem blood-an analysis with special reference to the cause of death and survival time. Forensic Sci. Int. 2002, 130:160-166.
55. Reichelt U., Jung R., Nierhaus A., Tsokos M. Serial monitoring of interleukin-1β, soluble interleukin-2 receptor and lipopolysaccharide binding protein levels after death. A comparative evaluation of potential postmortem markers of sepsis. Int. J. Legal Med. 2005, 119:80-87.
56. Mimasaka S., Ohtsu Y., Tsunenari S., Funayama M. Postmortem cytokine levels and severity of traumatic injuries. Int. J. Legal Med. 2006, 120:265-270.
57. Mimasaka S., Funayama M., Hashiyada M., Nata M., Tsunenari S. Significance of levels of IL-6 and IL-8 after trauma: a study of 11 cytokines post-mortem using multiplex immunoassay. Injury 2007, 38:1047-1051.
58. Tsokos M. Postmortem diagnosis of sepsis. Forensic Sci. Int. 2007, 165:155-164.
59. Astrup B.S., Thomsen J.L. The routine use of C-reactive protein in forensic investigations. Forensic Sci. Int. 2007, 172:49-55.
60. Schrag B., Roux-Lombard P., Schneiter D., Vaucher P., Mangin P., Palmiere C. Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as diagnostic parameters in sepsis-related fatalities. Int. J. Legal Med. 2012, 126:505-512.
61. Schrag B., Iglesias K., Mangin P., Palmiere C. Procalcitonin and C-reactive protein in pericardial fluid for postmortem diagnosis of sepsis. Int. J. Legal Med. 2012, 126:567-572.
62. Augsburger M., Iglesias K., Bardy D., Mangin P., Palmiere C. Diagnostic value of lipopolysaccharide-binding protein and procalcitonin for sepsis diagnosis in forensic pathology. Int. J. Legal Med. 2012, 10.1007/s00414-012-0780-9.
63. Wolfsdorf J., Craig M.E., Daneman D., Dunger D., Edge J., Lee W.R., Rosenbloom A., Sperling M.A., Hanas R. International society for pediatric and adolescent diabetes, diabetic ketoacidosis. Pediatr. Diabetes 2007, 8:28-43.
64. Wolfsdorf J., Craig M.E., Daneman D., Dunger D., Edge J., Lee W.R., Rosenbloom A., Sperling M.A., Hanas R. Diabetic ketoacidosis in children and adolescents with diabetes. Pediatr. Diabetes 2009, 10(Suppl):118-133.
65. Rosenbloom A.L. The management of diabetic ketoacidosis in children. Diabetes Ther. 2010, 1:103-120.
66. Bajwa S.J., Jindal R. Endocrine emergencies in critically ill patients: challenges in diagnosis and management. Indian J. Endocrinol. Metab. 2012, 16:722-727.
67. Blouin D. Too much of a good thing: management of diabetic ketoacidosis in adults. Can. Fam. Physician 2012, 58:55-57.
68. Smiley D., Chandra P., Umpierrez G.E. Update on diagnosis, pathogenesis and management of ketosis-prone Type 2 diabetes mellitus. Diabetes Manage. (Lond.) 2011, 1:589-600.
69. Isidro M.L., Jorge S. Recreational drug abuse in patients hospitalized for diabetic ketosis or diabetic ketoacidosis. Acta Diabetol. 2010, 10.1007/s00592-010-0243-z.
70. Umpierrez G.E., Kelly J.P., Navarrete J.E., Casals M.M., Kitabchi A.E. Hyperglycemic crises in urban blacks. Arch. Intern. Med. 1997, 157:669-675.
71. Warner E.A., Greene G.S., Buchsbaum M.S., Cooper D.S., Robinson B.E. Diabetic ketoacidosis associated with cocaine use. Arch. Intern. Med. 1998, 14:1799-1802.
72. Abraham M.R., Khardori R. Hyperglycemic hyperosmolar nonketotic syndrome as initial presentation of type 2 diabetes in a young cocaine abuser. Diabetes Care 1999, 22:1380-1381.
73. Ng R.S., Darko D.A., Hillson R.M. Street drug use among young patients with Type 1 diabetes in the UK. Diabet. Med. 2004, 21:295-296.
74. Nyenwe E.A., Loganathan R.S., Blum S., Ezuteh D.O., Erani D.M., Wan J.Y., Palace M.R., Kitabchi A.E. Active use of cocaine: an independent risk factor for recurrent diabetic ketoacidosis in a city hospital. Endocr. Pract. 2007, 13:22-29.
75. Burillo-Putze G., Gálvez Rodríguez M., Martín Cabrera F., Mora Quintero M.L. Diabetic ketoacidosis and cocaine use. Med. Clin. (Barc) 2003, 120:158.
76. Arbol Linde F., Marcos Sánchez F., Merlo González V., López Onega P. Diabetic ketoacidosis and cocaine use. Med. Clin. (Barc) 2003, 121:279.
77. Arbol Linde F., Merlo González V., Marcos Sánchez F., Maldonado Castro G., Juárez González R., López Onega P. Un caso de cetoacidosis diabética e hipotermia severa en consumidor de cocaina. Invest. Clin. 2001, 4:51-53.
78. Cohen D., Correll C.U. Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need. J. Clin. Psychiatry 2009, 70:765-766.
79. Kahn D., Bourgeois J.A. Acute pancreatitis and diabetic ketoacidosis in a schizophrenic patient taking olanzapine. J. Clin. Psychopharmacol. 2007, 27:397-400.
80. Ramaswamy K., Kozma C.M., Nasrallah H. Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine. Drug Saf. 2007, 30:589-599.
81. Henderson D.C., Cagliero E., Copeland P.M., Louie P.M., Borba C.P., Fan X., Freudenreich O., Goff D.C. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. J. Clin. Psychiatry 2007, 68:533-541.
82. Scheen A.J., De Hert M.A. Abnormal glucose metabolism in patients treated with antipsychotics. Diabetes Metab. 2007, 33:169-175.
83. House C.J. Olanzapine-induced hyperglycemic ketoacidosis and corresponding acetone concentrations post-mortem: a forensic interpretation. Forensic Sci. Int. 2007, 171:22-26.
84. Avella J., Wetli C.V., Wilson J.C., Katz M., Hahn T. Fatal olanzapine-induced hyperglycemic ketoacidosis. Am. J. Forensic Med. Pathol. 2004, 25:172-175.
85. Ali Z., Levine B., Ripple M., Fowler D.R. Diabetic ketoacidosis: a silent death. Am. J. Forensic Med. Pathol. 2012, 33:189-193.
86. Coe J.I. Use of chemical determinations on vitreous humor in forensic pathology. J. Forensic Sci. 1972, 17:541-546.
87. Coe J.I. Postmortem chemistry of blood, cerebrospinal fluid, and vitreous humor. Forensic Medicine 1977, vol. 2:1030-1060. W.B. Saunders, Philadelphia.
88. Coe J.I. Postmortem chemistry of blood, cerebrospinal fluid, and vitreous humor. Leg. Med. Annu. 1977, 1976:55-92.
89. DiMaio V.J., Sturner W.Q., Coe J.I. Sudden and unexpected deaths after the acute onset of diabetes mellitus. J. Forensic Sci. 1977, 22:147-151.
90. Kuroda N., Murai T., Shinozuka T., Kurihara K., Yanagida Y., Wanatabe H. Unexpected death of a young man suspected of having diabetes mellitus. Nihon. Hoigaku Zasshi. 1986, 40:384-387.
91. Irwin J., Cohle S.D. Sudden death due to diabetic ketoacidosis. Am. J. Forensic Med. Pathol. 1988, 9:119-121.
92. Coe J.I. Sudden death due to ketoacidosis: medline search. Am. J. Forensic Med. Pathol. 1989, 10:269-270.
93. Rozin L., Perper J.A., Jaffe R., Drash A. Sudden unexpected death in childhood due to unsuspected diabetes mellitus. Am. J. Forensic Med. Pathol. 1994, 15:251-256.
94. Yamazaki M., Ogura Y., Wakasugi C., Mitsukuni Y., Yoshimura M. Sudden death due to diabetic coma in insulin-department diabetes mellitus: an autopsy report. Nihon. Hoigaku Zasshi. 1997, 51:102-110.
95. Khuu H.M., Robinson C.A., Brissie R.M., Konrad R.J. Postmortem diagnosis of unsuspected diabetes mellitus established by determination of decedent's hemoglobin A1c level. J. Forensic Sci. 1999, 44:643-646.
96. Mizutani T., Yoshimoto T., Kaneko R., Ishii A. Diagnosis of fulminant type 1 diabetes mellitus in an autopsy case with postmortem changes. Leg. Med. (Tokyo) 2011, 13:250-253.
97. Hockenhull J., Dhillo W., Andrews R., Paterson S. Investigation of markers to indicate and distinguish death due to alcoholic ketoacidosis, diabetic ketoacidosis and hyperosmolar hyperglycemic state using postmortem samples. Forensic Sci. Int. 2012, 214:142-147.
98. Karavanaki K., Kakleas K., Georga S., Bartzeliotou A., Mavropoulos G., Tsouvalas M., Vogiatzi A., Papassotiriou I., Karayianni C. Plasma high sensitivity C-reactive protein and its relationship with cytokine levels in children with newly diagnosed type 1 diabetes and ketoacidosis. Clin. Biochem. 2012, 45:1383-1388.
99. Karavanaki K., Karanika E., Georga S., Bartzeliotou A., Tsouvalas M., Konstantopoulos I., Fotinou A., Papassotiriou I., Karayianni C. Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM). Endocr. J. 2011, 58:1045-1053.
100. Rains J.L., Jain S.K. Hyperketonemia increases monocyte adhesion to endothelial cells and is mediated by LFA-1 expression in monocytes and ICAM-1 expression in endothelial cells. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E298-E306.
101. Razavi Nematollahi L., Kitabchi A.E., Stentz F.B., Wan J.Y., Larijani B.A., Tehrani M.M., Gozashti M.H., Omidfar K., Taheri E. Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism 2009, 58:443-448.
102. Rosa J.S., Flores R.L., Oliver S.R., Pontello A.M., Zaldivar F.P., Galassetti P.R. Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus. Pediatr. Diabetes 2008, 9:9-16.
103. Dandona P., Chadhuri A., Ghanim H., Mohanty P. Anti-inflammatory effects of insulin and the pro-inflammatory effects of glucose. Semin. Thorac. Cardiovasc. Surg. 2006, 18:293-301.
104. Dandona P., Chadhuri A., Ghanim H., Mohanty P. Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. Am. J. Cardiol. 2007, 99:15B-26B.
105. Hoffmann W.H., Casanova M.F., Cudrici C.D., Zakranskaia E., Venugopalan R., Nag S., Oglesbee M.J., Rus H. Neuroinflammatory response of the choroid plexus epithelium in fatal diabetic ketoacidosis. Exp. Mol. Pathol. 2007, 83:65-72.
106. Stentz F.B., Umpierrez G.E., Cuervo R., Kitabchi A.E. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 2004, 53:2079-2086.
107. Hoffman W.H., Burek C.L., Waller J.L., Fisher L.E., Khichi M., Mellick L.B. Cytokine response to diabetic ketoacidosis and its treatment. Clin. Immunol. 2003, 108:175-181.
108. Dalton R.R., Hoffman W.H., Passmore G.G., Martin S.L. Plasma C-reactive protein levels in severe diabetic ketoacidosis. Ann. Clin. Lab. Sci. 2003, 33:435-442.
109. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., Quagliaro L., Ceriello A., Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072.
110. Gogos C.A., Giali S., Paliogianni F., Dimitracopoulos G., Bassaris H.P., Vagenakis A.G. Interleukin-6 and C-reactive protein as early markers of sepsis in patients with diabetic ketoacidosis or hyperosmosis. Diabetologia 2001, 44:1011-1014.
111. Morohoshi M., Fujisawa K., Uchimura I., Numano F. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 1996, 45:954-959.
112. O'Riordain M.G., Ross J.A., Fearon K.C., Maingay J., Farouk M., Garden O.J., Carter D.C. Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am. J. Physiol. 1995, 269:E323-E330.
113. Campos S.P., Baumann H. Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. Mol. Cell. Biol. 1992, 12:1789-1797.
114. Lindroos-Jokinen K., Keltanen T., Vanhala T., Valonen T., Sajantila A. Postmortem measurement of C-reactive protein and interpretation of results in ketoacidosis. Leg. Med. (Tokyo) 2012, 14:140-146.